Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells
T. M. Zikry, S. C. Wolff, J. S. Ranek…·J. E. Purvis
This study identifies cell cycle plasticity as a mechanism for fractional resistance to palbociclib in ER+/HER2- breast tumor cells using single-cell imaging and computational analysis.